Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dihydroartemisinin-piperaquine dose justification and tolerability study in Malawian children with uncomplicated falciparum malaria
PACTR201303000506302Completed
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- Nov 2014
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dihydroartemisinin and piperaquine in Malaria, sponsored by Liverpool School of Tropical Medicine. Started Nov 2014; status: completed.
02
Drugs
dihydroartemisininpiperaquine
03
Conditions
Malaria
Beyond the preview
Go deeper on PACTR201303000506302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201303000506302.